Improving preparedness for introducing and scaling up long-acting HIV pre-exposure prophylaxis in Asia
{{output}}
Long-acting injectable PrEP, particularly cabotegravir (CAB-LA), has the potential to enhance HIV prevention in Asia, and was the topic of a roundtable held in Singapore in June 2023. Despite proven efficacy, CAB-LA's impact in Asia is hindered by regulatory, ... ...
